During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Patient centricity is a priority for Merck and its Executive Vice President and Head of EMEA Region for Merck Biopharma Global Commercial Operations, Chris Round, outlines what practical steps the ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Walter Kraft is a paid consultant of Merck. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial ...

After hours: March 21 at 7:51:50 PM EDT ...

MJP Aluminium Premium: Market dynamics and its evolving role in Asia What Happened in the Cobalt Market After the DRC's Export Ban? And What's Next? Applications for the Palladium Global Science Award ...